Wound Treatments in Turkey

Publication Date	April 2009
Publisher	Euromonitor
Product Type	Report
Pages	28
ISBN Number	not applicable
Product Code	EUR00338

Buy this product or for assistance call +44 20 7060 7474

PDF £560.00$932 | €627

PRINT £560.00$932 | €627

FAX Order above formats by FAX

Summary

Euromonitor International's Wound Treatments in Turkey report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: sticking plasters, other wound treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

Get a detailed picture of the wound treatments industry
Identify growth sectors and factors driving change
Understand the competitive environment, the market's major players and leading brands
Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Content

Wound Treatments in Turkey
Euromonitor International
April 2009
Executive Summary
State Endeavours To Strengthen Competitive Power of Generics
Legislative Changes Slow Introduction of OTC Healthcare Concept
Novartis Leads, Followed by Sandoz
Pharmacies the Dominant Retail Channel
Social Security and General Health Insurance Law Will Lead To Constant Value Decline Over Forecast Period
Key Trends and Developments
New National Health System Triggers Volume Growth But Constant Unit Prices Decline
Private Health Insurances Have Positive Impact
Original Patent Time Limits Start To Expire, Number of Generics Increases
Increased Number of Pharmacies Could Not Resolve the Distribution Issue Yet
OTC Regulations Likely To Be Enacted by 2010
Market Indicators
Market Data
$1OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing Or De-reimbursement
Traditional Remedies
Homeopathy
Consumer Expenditure on Health Goods and Medical Services
Self-medication and Preventative Medicine
Generics
Switches
Definitions
Abdi Ibrahim Ila Sanayi Ve Ticaret As
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Bilim Ilac Sanayi Ve Ticaret As
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Deva Holding As
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Eczacibasi Ilac Sanayi Ve Ticaret As
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Nobel Ilac Sanayi Ve Ticaret As
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Overview
Sector Data
List of Summaries
- Summary 1 Research Sources
- Summary 2 Abdi Ibrahim Ilac Sanayi AS: Key Facts
- Summary 3 Abdi Ibrahim Ilac Sanayi AS: Operational Indicators 2005-2007
- Summary 4 Abdi Ibrahim Ilac Sanayi AS: Competitive Position 2008
- Summary 5 Bilim Ilac Sanayi ve Ticaret AS: Key Facts
- Summary 6 Bilim Ilac Sanayi ve Ticaret AS: Operational Indicators 2005-2007
- Summary 7 Bilim Ilac Sanayi ve Ticaret AS: Competitive Position 2008
- Summary 8 Deva Holding AS: Key Facts
- Summary 9 Deva Holding AS: Operational Indicators 2005-2007
- Summary 10 Deva Holding AS: Competitive Position 2008
- Summary 11 Eczacibasi Ilac Sanayi ve Ticaret AS: Key Facts
- Summary 12 Eczacibasi Ilac Sanayi ve Ticaret AS: Operational Indicators 2005-2007
- Summary 13 Eczacibasi Ilac Sanayi ve Ticaret AS: Competitive Position 2008
- Summary 14 Nobel Ilac Sanayi ve Ticaret AS: Key Facts
- Summary 15 Nobel Ilac Sanayi ve Ticaret AS: Operational Indicators 2005-2007
- Summary 16 Nobel Ilac Sanayi ve Ticaret AS: Competitive Position 2008
List of Tables
- Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
- Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
- Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
- Table 11 Sales of Wound Treatments by Subsector: Value 2003-2008
- Table 12 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
- Table 13 Wound Treatments Company Shares by Value 2004-2008
- Table 14 Wound Treatments Brand Shares by Value 2005-2008
- Table 15 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
- Table 16 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013